Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17

Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17

Ding-Siang Huang,1,* Hsuan-Yuan Lin,1,2,* Guey-Jen Lee-Chen,1 Hsiu-Mei Hsieh-Li,1 Chung-Hsin Wu,1 Jung-Yaw Lin1,21Department of Life Science, National Taiwan Normal University, 2Institute of Biochemistry and Molecular Biology, National Taiwan University, Taipei City, Taiwan, Republic of China*These...

Full description

Bibliographic Details
Main Authors: Huang DS, Lin HY, Lee-Chen GJ, Hsieh-Li HM, Wu CH, Lin JY
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Drug Design, Development and Therapy
Subjects:
Spinocerebellar ataxia type 17
excitotocicity
EGb761
polyQ diseases
apoptosis
Online Access:https://www.dovepress.com/treatment-with-a-ginkgo-biloba-extract-egb-761-inhibits-excitotoxicity-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/treatment-with-a-ginkgo-biloba-extract-egb-761-inhibits-excitotoxicity-peer-reviewed-article-DDDT

Similar Items